Refine by
Medical Flow Selector Device Services In Japan
7 services found
Manufactured by:Nanosonics, Inc. based inSydney, AUSTRALIA
Disinfection is the process by which microorganisms are destroyed in order to prevent transmission to the next patient via a medical ...
Manufactured by:Nanosonics, Inc. based inSydney, AUSTRALIA
Traceability is the documentation collected to link medical devices and their reprocessing records with patient use. This process is essential for investigations in the event of reprocessing failures, outbreaks or recalls, and can help facilities manage risk. Traceability is required for semi-critical and critical medical devices that undergo HLD or sterilization. ...
Manufactured by:ASAHI INTECC CO., LTD. based inAichi, JAPAN
With a basic policy of investing at least 10% of net sales into R&D expenses, we continue to develop products while maintaining close ties to the medical ...
Manufactured by:Nanosonics, Inc. based inSydney, AUSTRALIA
Appropriate storage is required to prevent recontamination of reprocessed medical devices. Standard storage conditions such as being clean, dry, away from extreme heat and UV light should be ...
Manufactured by:Nanosonics, Inc. based inSydney, AUSTRALIA
Earle H. Spaulding recognised a disinfection framework was required since all reusable medical devices cannot be sterilized. The Spaulding Classification met a key unmet need that today still forms the basis of international medical device disinfection ...
by:CSA Group based inToronto, ONTARIO (CANADA)
Mitigate the risk of a cyber attack with thorough review and testing of your connected products and systems. Cybercrime damage costs are expected to hit $6 trillion annually by 2021, up from $3 trillion in 2015. IoT devices connect twice as many people that are alive in the world. In 2015, the FBI warned about the dangers of IoT, yet most devices are still considered vulnerable to attack. The ...
by:Teijin Limited based inTokyo, JAPAN
Focusing on the three key therapeutic areas: bone and joint, respiratory, and cardiovascular and metabolic diseases, the Teijin Group is promoting global business expansion led by the twin driving forces of pharmaceuticals and home ...